Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
EHD1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
IVD - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
NEUROG1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
PAN2 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
ANPEP - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
PARVB - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
CES2 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
GIPR - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
SURF1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
SLC9A3R2 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
PEX19 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
AKAP8L - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
CA5BP1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
GEO DataSets Gene Profile neighbors Chromosome neighbors
OGFR - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
SPACA1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
C3 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
TMEM183B - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
SOX1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
GRIA3 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
NEFL - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on